Body weight changes and outpatient medical care utilisation: Results of the MONICA/KORA cohorts S3/F3 and S4/F4.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 3488805)

Published in Psychosoc Med on October 25, 2012

Authors

Silke B Wolfenstetter1, Petra Menn, Rolf Holle, Andreas Mielck, Christa Meisinger, Thomas von Lengerke

Author Affiliations

1: Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Health Economics and Health Care Management, Neuherberg, Germany.

Articles cited by this

Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79

Inequalities in access to medical care by income in developed countries. CMAJ (2006) 6.44

Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab (2008) 4.86

KORA--a research platform for population based health research. Gesundheitswesen (2005) 3.95

Obesity prevalence from a European perspective: a systematic review. BMC Public Health (2008) 3.67

National health surveys and the behavioral model of health services use. Med Care (2008) 3.36

The medical complications of obesity. QJM (2006) 2.93

Moderate and severe obesity have large differences in health care costs. Obes Res (2004) 2.43

Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med (2008) 2.07

Economic costs of obesity. Am J Clin Nutr (1992) 1.75

Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev (2006) 1.74

Health-economic burden of obesity in Europe. Eur J Epidemiol (2008) 1.54

Trend in obesity prevalence in European adult cohort populations during follow-up since 1996 and their predictions to 2015. PLoS One (2011) 1.40

[Predictors for ambulatory medical care utilization in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2005) 1.36

Communication in general practice: differences between European countries. Fam Pract (2003) 1.23

[The development of obesity in Germany in the period from 1985 until 2000]. Gesundheitswesen (2004) 1.08

Predictors of overweight and obesity in five to seven-year-old children in Germany: results from cross-sectional studies. BMC Public Health (2008) 1.06

Copayments for ambulatory care in Germany: a natural experiment using a difference-in-difference approach. Eur J Health Econ (2009) 1.04

Economic costs of adult obesity: a review of recent European studies with a focus on subgroup-specific costs. Maturitas (2011) 0.98

[Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-study region (Augsburg, Germany)]. Gesundheitswesen (2006) 0.97

Utilization of out- and inpatient health services by obese adults: a population-based study in the Augsburg region, Germany. Gesundheitswesen (2005) 0.92

Future direct and indirect costs of obesity and the influence of gaining weight: results from the MONICA/KORA cohort studies, 1995-2005. Econ Hum Biol (2011) 0.91

Are German patients burdened by the practice charge for physician visits ('Praxisgebuehr')? A cross sectional analysis of socio-economic and health related factors. BMC Health Serv Res (2008) 0.91

Use of medical doctors, physical therapists, and alternative practitioners by obese adults: does body weight dissatisfaction mediate extant associations? J Psychosom Res (2006) 0.90

Relationship of BMI, waist circumference, and weight change with use of health services by older adults. Obes Res (2005) 0.89

Excess direct medical costs of severe obesity by socioeconomic status in German adults. Psychosoc Med (2010) 0.87

Overweight and obesity and the utilization of primary care physicians. Health Econ (2011) 0.86

[Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis]. Gesundheitswesen (2006) 0.82

Excess use of general practitioners by obese adults: does health-related quality of life account for the association? Psychol Health Med (2007) 0.82

Healthcare costs and obesity prevention: drug costs and other sector-specific consequences. Pharmacoeconomics (2009) 0.80

[Efficient prevention of overweight and obesity in the experience of family practitioners and "nutrition units" of the public health system in Lombardy]. Ann Ig (2006) 0.78

Articles by these authors

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet (2012) 8.42

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation (2008) 5.20

New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet (2009) 5.12

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet (2008) 4.67

Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet (2009) 4.63

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88

Trends in socioeconomic inequalities in self-assessed health in 10 European countries. Int J Epidemiol (2004) 3.57

Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Re-revisiting Andersen's Behavioral Model of Health Services Use: a systematic review of studies from 1998-2011. Psychosoc Med (2012) 3.02

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One (2010) 2.84

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53

Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol (2012) 2.39

Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care (2007) 2.30

Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17

Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care (2007) 2.13

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med (2003) 2.05

Depression and anxiety in labor migrants and refugees--a systematic review and meta-analysis. Soc Sci Med (2009) 2.02

Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes (2005) 1.98

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation (2004) 1.93

Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet (2011) 1.92

Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem (2007) 1.88

Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res (2005) 1.86

A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood (2009) 1.85

A genome-wide association study of metabolic traits in human urine. Nat Genet (2011) 1.84

Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur Heart J (2006) 1.82

Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care (2007) 1.80

A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72

Multiple loci are associated with white blood cell phenotypes. PLoS Genet (2011) 1.65

Prolonged recruitment efforts in health surveys: effects on response, costs, and potential bias. Epidemiology (2006) 1.64

C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation (2004) 1.61

Patterns of multimorbidity in the aged population. Results from the KORA-Age study. PLoS One (2012) 1.58

A claims data-based comparison of comorbidity in individuals with and without dementia. BMC Geriatr (2014) 1.58

Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med (2010) 1.56

Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc (2002) 1.54

Air temperature and the occurrence of myocardial infarction in Augsburg, Germany. Circulation (2009) 1.53

Intensity of physical exertion and triggering of myocardial infarction: a case-crossover study. Eur Heart J (2008) 1.52

Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol (2006) 1.50

Presenting symptoms of myocardial infarction predict short- and long-term mortality: the MONICA/KORA Myocardial Infarction Registry. Am Heart J (2012) 1.47

Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol (2006) 1.46

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study. Eur J Epidemiol (2007) 1.41

Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37

Regional and neighborhood disparities in the odds of type 2 diabetes: results from 5 population-based studies in Germany (DIAB-CORE consortium). Am J Epidemiol (2013) 1.35

Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS One (2011) 1.35

Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med (2009) 1.35

Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes (2005) 1.30

Analysis of SF-6D index data: is beta regression appropriate? Value Health (2011) 1.30

Discovery and fine mapping of serum protein loci through transethnic meta-analysis. Am J Hum Genet (2012) 1.29

Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch Intern Med (2005) 1.28

Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood (2012) 1.26

Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet (2011) 1.26

Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23. Eur Heart J (2010) 1.25

Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet (2003) 1.24

Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study. PLoS One (2011) 1.21

Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol (2010) 1.21

Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol (2005) 1.19

Multimorbidity and health-related quality of life in the older population: results from the German KORA-age study. Health Qual Life Outcomes (2011) 1.18

IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes (2006) 1.18

Long-term exposure to ambient air pollution and incidence of cerebrovascular events: results from 11 European cohorts within the ESCAPE project. Environ Health Perspect (2014) 1.16

Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data. BMC Health Serv Res (2012) 1.16

Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur Heart J (2008) 1.16

Social inequality in perceived environmental exposures in relation to housing conditions in Germany. Environ Res (2005) 1.16

Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care (2006) 1.15

Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health (2011) 1.15

Inequalities in utilisation of general practitioner and specialist services in 9 European countries. BMC Health Serv Res (2011) 1.14

Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet (2012) 1.14

Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation. Diabetes Metab Res Rev (2011) 1.13

Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population. Am J Nephrol (2009) 1.13

Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002. Diabetes Care (2009) 1.13

Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study. Diabetes Care (2011) 1.13

Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis (2012) 1.12

DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet (2015) 1.12

Determinants of health policy impact: a theoretical framework for policy analysis. Soz Praventivmed (2003) 1.12

Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes (2010) 1.10

Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med (2009) 1.10

Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis (2008) 1.09

APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res (2007) 1.09

Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab (2008) 1.08